A

Alpha-9 Oncology

Develops targeted radiopharmaceuticals for cancer

Director, Program Management

Program ManagementUpdated on Nov 11
Full-timeBoston, MA, USAIn-person

About the Job

Requirements

  • A bachelor's degree in a scientific or related field with 10+ years of biotech or pharmaceutical experience, or an advanced degree with 7+ years of experience, including at least 5 years in drug development program or project management.
  • Strong understanding of the drug development lifecycle and interdependencies across Clinical, Regulatory, CMC, and nonclinical functions.
  • Experience supporting drug development programs through IND or CTA submission and into early-phase clinical development.
  • Direct experience coordinating cross-functional activities and inputs for regulatory submissions, key development milestones, and program deliverables.
  • Ability to develop and maintain integrated program plans, budgets, timelines, and long-range development strategies.
  • Experience identifying and managing program risks, assessing critical path implications, and proactively addressing issues that could affect program timelines or deliverables.
  • Ability to influence cross-functional stakeholders at all levels without direct authority, including CROs and external development partners.
  • Decision-making ability to frame options, assess trade-offs, and guide teams toward clear, data-driven decisions.
  • Experience working in both larger pharmaceutical organizations and lean, growing biotech environments, including establishing program management processes and infrastructure from the ground up.
  • Proficiency with Smartsheet, Microsoft Project, or similar project management tools.
  • Ability to translate complex program activities and status into concise, actionable updates for senior leadership.

Responsibilities

  • Partner with program leads to shape program priorities and the integrated development plan for assigned programs.
  • Serve as program manager for assigned programs, owning the integrated plan and driving execution with Clinical, Regulatory, CMC, and nonclinical teams.
  • Build program timelines and scenarios, mapping dependencies specific to radiopharmaceutical therapy, such as isotope supply, drug product manufacturing, and imaging agent availability.
  • Act as the team’s point person on program risk, identifying issues early and driving mitigation and contingency plans with functional leads.
  • Present program status, trade-offs, and options to program leads and the leadership team to support timely decisions.
  • Coordinate cross-functional inputs for key milestones, including IND and CTA filings, study starts, and data readouts.
  • Run program team meetings, owning agendas, decision logs, and follow-through on action items.
  • Establish program management tools, templates, and processes that scale with the company.
  • Manage program budgets and forecasts in partnership with Finance and functional leads.
  • Track deliverables from CROs, CDMOs, and isotope suppliers against the program plan, and escalate when timelines put milestones at risk.
  • Connect nonclinical, CMC, regulatory, and clinical plans as programs move from IND-enabling work into the clinic.

Desired Qualifications

  • An advanced degree in life sciences, an MBA, or PMP certification.
  • Oncology experience.

About the Company

Alpha-9 Oncology

Develops targeted radiopharmaceuticals for cancer

Alpha-9 Oncology develops targeted radiopharmaceuticals for cancer. It designs drug candidates that attach radioactive isotopes to molecules that bind specifically to cancer cells, so the radiation mostly hits tumors and spares healthy tissue. The company uses a toolbox of components (binders, linkers, chelators, and radioisotopes) and optimizes each part for stability, selectivity, and payload delivery, enabling rapid development of new medicines. Its programs include radiotherapeutics for solid and blood cancers and a radiodiagnostic imaging agent (A9-3202) for metastatic melanoma, with Lutetium-177 sourcing coordinated through a partner. Alpha-9 is backed by multiple funding rounds and has facilities in Boston and Vancouver to support research and manufacturing, as it advances its clinical pipeline through trials. The goal is to move their radiopharmaceuticals through clinical trials toward approved treatments that can target tumors effectively while reducing side effects.

Company size
11-50
Company stage
Series C
Total funding
$258.2M
Headquarters
Vancouver, Canada
Founded
2018

Recently Posted Jobs

Explore more opportunities at Alpha-9 Oncology

See more jobs